Why I think Aviva shares are a bargain right now

Here’s why Foolish contributor Tom Chen thinks Aviva shares are currently undervalued following a drop of around 35% since the beginning of the year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Aviva (LSE: AV) share price has been hit very hard by the coronavirus pandemic. After starting the year at 423.6p, the stock has fallen to levels not seen since 2009 and is currently down around 34% from the start of the year.

As a matter of fact, regardless of the pandemic, Aviva has struggled in recent years and its share price has been stuck in a tight range since 2014. With that in mind, in the midst of every crisis lies a great investment opportunity. Let me explain why I think Aviva shares are a bargain right now.

Aviva share price problems

The UK-based insurance company faces two main problems – the coronavirus pandemic that has lowered the demand for new insurance policies, and the ongoing Brexit situation that creates uncertainty, especially for financial-related companies. Further, Aviva is facing an embarrassing £450m rebuke over preference shares from the FCA.

So far, I believe the company was a bit passive in its response to the coronavirus crisis and the drop in revenues. Besides the new appointment of Amanda Blanc as the company’s new CEO, we haven’t heard too much from Aviva. 

Looking ahead, there’s no doubt that another economic turmoil could increase the uncertainty for Aviva’s investors. But at the same time, a rebound in Q3 would be unsurprising with the stock market recovery currently in action and the expected British government stimulus deal to maintain the economic momentum.

Ultimately, the pandemic has a double sword effect on insurance companies like Aviva. While the coronavirus adds uncertainty to the sector’s outlook, coronavirus-related claims may not be covered by insurance companies, and the demand for insurance policies is actually expected to rise.

Aviva: time to buy?

While the factors above remain important, they are already priced in the stock valuation. Aviva, which has operations in Europe, Asia, and North America, is still a huge company by any standard, with a market capitalisation of slightly above £11bn.

More importantly, Aviva reported a record of £3.2bn in operating profits in 2019 and the company’s financial performance in the first half-year of 2020 was relatively strong. This has led to the board’s decision to pay a second interim dividend of 6p per share for 2019, which basically means that Aviva is once again a paying dividend stock.  To further support Aviva’s financial stability, just a week ago Fitch Ratings has affirmed that the outlooks are stable and Britain’s second-largest insurer was rated at AA.

In my opinion, Aviva operates in an industry that will allow it to get stimulus funds if needed. And as governments continue to pour money into the markets, it is more than likely that we’ll see the Aviva share price rebound to pre-Covid 19 levels within the next one to five years. Evidently, the stock’s price-per-earnings ratio of 5.18 is way below the average in the industry and implies that the share price is undervalued. 

The bottom line is that I think Aviva shares look like a bargain right now. Considering the company’s outlook, I believe they could rise by at least 20% from current levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tom Chen has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »